Topadur Pharma
Founded 2015 · $2.3M raised
- Founded
- 2015
- Website
- topadur.com
- Total Funding
- $2.3M
- Last Round
- $2.3M Series AApr 2016
- Rounds
- 1
About
Topadur Pharma AG is a clinical-stage company developing novel therapies to restore healthy blood flow and stimulate tissue regeneration. The company focuses on challenging-to-treat age-related diseases characterized by microvascular dysfunction and impaired healing, with a precision-targeted approach aimed at localized healing with minimal systemic exposure. Founded in Switzerland in 2015, Topadur brings together pharma leaders and seasoned scientists driven by the belief that impaired microcirculation is a critical but often overlooked driver of disease progression.
Summary
Topadur Pharma is a Biotech company, founded in 2015. It has raised $2.3M in total across 1 round, most recently a $2.3M Series A round in Apr 2016. Investors include Innosuisse.
Funding History
Apr 2016
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/topadur-pharma"><img src="https://indexed.vc/api/badge/company/topadur-pharma" alt="Topadur Pharma on Indexed.vc" width="260" height="76" /></a>